fulphila 6 mg 0.6 ml solution for injection
biocon sdn bhd - pegfilgrastim -
pelgraz 6 mg solution for injection in a pre-filled syringe
accord healthcare sdn.bhd. - pegfilgrastim -
nyvepria solution
pfizer canada ulc - pegfilgrastim - solution - 6mg - pegfilgrastim 6mg - hematopoietic agents
fulphila solution
biosimilar collaborations ireland limited - pegfilgrastim - solution - 10mg - pegfilgrastim 10mg - hematopoietic agents
ziextenzo solution
sandoz canada incorporated - pegfilgrastim - solution - 6mg - pegfilgrastim 6mg - hematopoietic agents
lapelga solution
apotex inc - pegfilgrastim - solution - 6mg - pegfilgrastim 6mg - hematopoietic agents
lapelga solution
apotex inc - pegfilgrastim - solution - 6mg - pegfilgrastim 6mg
neulasta solution
amgen canada inc - pegfilgrastim - solution - 10mg - pegfilgrastim 10mg - hematopoietic agents
ziextenzo
sandoz new zealand limited - pegfilgrastim 10 mg/ml - solution for injection - 6 mg/0.6ml - active: pegfilgrastim 10 mg/ml excipient: acetic acid polysorbate 20 sodium hydroxide sorbitol water for injection - ziextenzo is indicated for the reduction in the duration of neutropenia, the incidence of febrile neutropenia and the incidence of infection as manifested by febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
fulphila™ solution for injection in prefilled syringe 6mg0.6ml
zuellig pharma pte. ltd. - pegfilgrastim - injection, solution - pegfilgrastim 6 mg / 0.6 ml